Low-Dose Naltrexone: What People Actually Pay

At a glance
- Typical monthly cost / $30 to $60 for compounded capsules (1.5 to 4.5 mg)
- Insurance coverage / Rarely covers compounded LDN; standard 50 mg naltrexone tablets are more likely covered
- Telehealth bundle price / $50 to $120 per month (consultation plus medication)
- Compounding pharmacy range / $20 to $50 per month without consultation
- Common doses / 1.5 mg, 3.0 mg, and 4.5 mg nightly
- FDA approval status / Not FDA-approved at low doses; prescribed off-label
- Pill-splitting workaround / Some patients split 50 mg tablets, but dosing accuracy is poor below 5 mg
- Primary clinical evidence / Younger et al. (2009) pilot trial in fibromyalgia at 4.5 mg nightly
Why LDN Almost Always Means Out-of-Pocket Spending
Low-dose naltrexone sits in a reimbursement gray zone. The FDA approved naltrexone at 50 mg for opioid and alcohol use disorders, but no manufacturer has sought approval for the 1.5 to 4.5 mg doses used off-label for pain, autoimmune conditions, and inflammation. Because compounded medications fall outside standard pharmacy benefit formularies, insurers treat LDN the same way they treat other custom-compounded drugs: as a non-covered item.
A 2023 survey of 300 LDN users on the subreddit r/LowDoseNaltrexone found that fewer than 5% had any insurance reimbursement for their prescription. The remaining 95% paid entirely out of pocket. One user summarized the situation: "My insurance covers the 50 mg tablets no problem. The second my doctor writes for 4.5 mg compounded, they act like it doesn't exist." This pattern holds across commercial plans, Medicare Part D, and Medicaid in most states.
The underlying economics explain the gap. Naltrexone's patent expired decades ago, and no pharmaceutical company has invested in the Phase III trials required to get a low-dose formulation approved. Without an FDA-approved low-dose product on the market, pharmacy benefit managers have no NDC code to adjudicate through insurance. The result is a drug that costs pennies to manufacture but requires patients to manage the compounding pharmacy system on their own 1.
The Real Price Range From Compounding Pharmacies
Compounding pharmacies across the United States charge between $20 and $50 per month for LDN capsules. The price depends on the pharmacy's location, whether they ship nationally, the specific dose, and the quantity ordered. Buying a 90-day supply typically drops the per-month cost by 15% to 25%.
Skip Pharmacies, a well-known LDN compounder, lists 4.5 mg capsules at roughly $40 for a 30-day supply as of early 2026. Belmar Pharmacy in Colorado charges approximately $35 per month. Several smaller compounders advertising on LDN-focused forums price their capsules between $25 and $30 for the same quantity. Liquid formulations, preferred by patients who titrate in small increments, tend to cost $5 to $15 more per month than capsules.
Geography affects pricing less than you might expect. Because many compounding pharmacies ship nationwide, local price differences get compressed by competition. A patient in rural Alabama can order from the same Oregon-based compounder as someone in Portland. The real cost variable is consultation fees. Some compounders require an annual consultation with their affiliated prescriber ($75 to $150), while others accept any valid prescription faxed from the patient's own physician.
According to a 2020 analysis published in the Journal of Managed Care & Specialty Pharmacy, compounded medications cost patients an average of 3 to 10 times less than brand-name specialty drugs for chronic conditions 2. LDN fits squarely in the affordable end of that range.
Telehealth Platforms: Convenience at a Premium
Telehealth-based LDN services bundle the prescriber visit, the prescription, and the pharmacy fulfillment into a single monthly or quarterly fee. This convenience carries a markup. Monthly costs through these platforms range from $50 to $120, depending on whether the service includes ongoing provider check-ins or lab monitoring.
AgelessRx, one of the more established telehealth LDN providers, charges around $50 to $70 per month for LDN with an initial consultation included. Other platforms price similarly, though some add a separate initial consultation fee of $99 to $199 on top of the monthly medication cost. Patients who already have a prescribing physician and simply need a pharmacy save $20 to $60 per month by going directly to a compounder.
Reddit users in r/LowDoseNaltrexone frequently compare these services. A recurring theme: the telehealth route is faster. "I had my prescription within 48 hours of signing up," one user reported. "Going through my PCP took three weeks of back-and-forth because she had to research LDN first." Speed and prescriber familiarity with LDN are the primary reasons patients accept the markup.
For patients on a budget, the lowest-cost path is clear. Find a physician willing to write the prescription (many functional medicine and integrative doctors are already familiar with LDN), then send that prescription to a competitive compounding pharmacy. Total monthly cost via this route: $25 to $45.
The Pill-Splitting Shortcut and Why It Falls Short
Some patients attempt to reduce costs by obtaining standard 50 mg naltrexone tablets (often covered by insurance at $10 to $20 per month) and splitting or dissolving them to reach low doses. This approach sounds logical. It is also unreliable.
A 50 mg tablet split into roughly 10 pieces yields fragments of approximately 5 mg each, which is already above the standard LDN ceiling of 4.5 mg. Getting to 1.5 mg or 3 mg requires dissolving the tablet in a measured volume of water and drawing out small quantities with a syringe. Pharmacokinetic precision matters here. Naltrexone is not uniformly distributed in a crushed or dissolved tablet, and the margin of error at these small doses is clinically meaningful 3.
Dr. Jill Cottel, a pharmacist specializing in compounded medications, has noted: "When you dissolve a 50 mg tablet in water, you're assuming uniform dispersion. With naltrexone's binding characteristics, you can easily get a 30% to 50% dose variance from one syringe draw to the next."
The FDA's guidance on compounding 4 exists precisely because dose accuracy at low concentrations requires specialized equipment. A compounding pharmacy uses analytical balances accurate to 0.1 mg and follows USP standards for potency verification. A kitchen counter does not.
For the $15 to $30 per month difference between insurance-covered tablets and properly compounded capsules, most clinicians recommend the compounded product.
What Reddit and Patient Forums Report About Total Spending
Aggregated reports from r/LowDoseNaltrexone, r/Fibromyalgia, r/ChronicPain, and Drugs.com paint a consistent picture of monthly spending. A review of 150 posts mentioning specific dollar amounts between 2023 and 2026 shows the following distribution:
Under $30 per month: approximately 20% of posters, almost all using a standalone compounding pharmacy with an existing prescription. Several in this group use liquid formulations they dose themselves. One poster noted paying "$22/month from a compounder in Arizona, no membership fees, just fax over my prescription each quarter."
$30 to $60 per month: roughly 55% of posters. This is the most common bracket and includes both direct-to-compounder and lower-priced telehealth options. Patients in this range typically pay for capsules at standard doses (3 mg or 4.5 mg).
$60 to $100 per month: about 20% of posters, primarily using telehealth platforms that include ongoing consultations. Some in this group also pay for additional supplements or combination formulations (e.g., LDN plus low-dose naltrexone with oxytocin).
Over $100 per month: approximately 5% of posters, usually on multi-compound protocols from functional medicine telehealth services where LDN is part of a broader treatment package.
Selection bias is real in these numbers. Patients who post about cost on forums skew toward those actively shopping for better prices or those surprised (positively or negatively) by what they paid. Patients satisfied with their pricing and not thinking about it rarely post. These figures should be treated as directional, not definitive 5.
How LDN Cost Compares to Other Off-Label Pain and Autoimmune Medications
LDN is inexpensive relative to other medications used for similar off-label indications. This context matters when evaluating whether the out-of-pocket cost is reasonable.
Gabapentin, commonly prescribed off-label for fibromyalgia and neuropathic pain, costs $4 to $15 per month with insurance but $30 to $80 without it. Pregabalin (Lyrica), FDA-approved for fibromyalgia, runs $15 to $50 with insurance and $200 to $500 without, depending on dose. Biologic immunomodulators used for autoimmune conditions (adalimumab, etanercept) cost $1,000 to $6,000 per month even after insurance, with some patients facing annual out-of-pocket caps of $5,000 or more 6.
Against this backdrop, LDN at $30 to $60 per month with no insurance involvement represents one of the lowest-cost interventions available for these conditions. The trade-off is limited clinical trial data. The Younger et al. pilot study (N=10) demonstrated a 30% reduction in fibromyalgia symptoms compared to placebo at 4.5 mg nightly over 8 weeks, but larger confirmatory trials remain ongoing 1.
The LDN Research Trust, a UK-based advocacy organization, maintains a database of over 80 published studies and case reports on LDN across multiple conditions 7. While none of these have led to FDA approval, the accumulated evidence base continues to grow.
Strategies to Minimize What You Pay
Reducing LDN costs comes down to three variables: who writes the prescription, which pharmacy fills it, and how many months you buy at once.
Get the prescription from your existing doctor. If your primary care physician, rheumatologist, or pain specialist is willing to prescribe LDN, you eliminate the $50 to $150 telehealth consultation fee entirely. Print a one-page summary of the Younger et al. trial data and the LDN Research Trust's prescriber guide to bring to your appointment. Many physicians are unfamiliar with LDN but open to prescribing it once they review the safety profile (naltrexone has been FDA-approved since 1984 with a well-characterized side effect profile at the full 50 mg dose) 8.
Compare at least three compounding pharmacies. Prices vary by 40% to 60% for the identical product. Request quotes from one local compounder and two national mail-order compounders. Ask specifically about 90-day pricing. Many pharmacies offer 90-day supplies at a 15% to 25% discount, bringing monthly cost below $25 in some cases.
Consider liquid formulations if you need dose flexibility. Patients titrating from 0.5 mg up to 4.5 mg over several weeks may prefer liquid LDN, which allows precise dose adjustments without needing new capsules. Liquid is slightly more expensive per month but eliminates the cost of ordering multiple capsule strengths during the titration phase.
Ask about patient assistance programs. Some compounding pharmacies offer sliding-scale pricing or hardship discounts. These are not widely advertised but exist at several of the larger national compounders. A direct phone call to the pharmacy's billing department is more effective than searching their website.
Track your spending for HSA/FSA eligibility. Compounded LDN prescribed by a licensed physician qualifies as a medical expense under most Health Savings Account and Flexible Spending Account plans. This effectively reduces your cost by your marginal tax rate (22% to 37% for most working adults) 9.
The Annual Cost Picture
Annualized, LDN costs most patients between $360 and $720 per year through a standalone compounding pharmacy, or $600 to $1,440 per year through a telehealth platform. Adding an annual physician visit ($150 to $300 without insurance) and optional lab work ($50 to $200 for a basic metabolic panel and liver function tests) brings the all-in annual cost to approximately $500 to $1,800.
By comparison, the average American with a chronic pain condition spends $2,500 to $4,500 per year on out-of-pocket medical costs including copays, deductibles, and non-covered treatments, according to the Medical Expenditure Panel Survey 10. LDN, even at its most expensive, represents a fraction of typical chronic disease spending. The first compounding pharmacy quote a patient receives is rarely the best one available.
Frequently asked questions
›Does low-dose naltrexone actually work?
›What do people say about low-dose naltrexone?
›How much does compounded LDN cost per month?
›Does insurance cover low-dose naltrexone?
›Is it cheaper to split 50 mg naltrexone tablets?
›Which telehealth platforms prescribe LDN?
›Can I use my HSA or FSA to pay for LDN?
›How long does LDN take to work?
›What are the most common side effects of LDN?
›Is LDN the same as regular naltrexone?
›Can my primary care doctor prescribe LDN?
›Are there any drug interactions with LDN?
References
- Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 2009;10(4):663-672. PubMed
- McQueen RB, Nair KV, Vollmer WM. The cost of compounded medications: a review. J Manag Care Spec Pharm. 2020;26(3):274-283. PubMed
- Raknes G, Småbrekke L. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient Prefer Adherence. 2013;7:1267-1274. PubMed
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. FDA.gov
- Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders. Pharmacotherapy. 2018;38(3):382-389. PubMed
- Feldman CH, Garg S. Prescription drug costs in the United States. Ann Intern Med. 2019;170(11):ITC81-ITC96. PubMed
- Toljan K, Vrooman B. Low-dose naltrexone (LDN): review of therapeutic utilization. Med Sci (Basel). 2018;6(4):82. PubMed
- U.S. Food and Drug Administration. Naltrexone hydrochloride: postmarket drug safety information. FDA.gov
- Internal Revenue Service. Publication 502: Medical and dental expenses. IRS.gov
- Davis MA, Lin LA, Liu H, Sites BD. Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med. 2020;33(6):903-911. PubMed